Willkommen bei Valicare!
-
Unsere Experten bieten GMP-Beratung, Konzeptionierung und Unterstützung vor Ort!
Rufen Sie an: +49 69 153 293 701
Mehr erfahren -
Unsere Experten bieten GMP-Beratung, Konzeptionierung und Unterstützung vor Ort!
Rufen Sie an: +49 69 153 293 701
Mehr erfahren
Events
-
15 Okt 2020Frankfurt am Main / Deutschland GMP-Schulung für ATMPs Diese Schulung befasst sich speziell mit den GMP-Vorgaben für ATMPs.
-
20 Okt 2020Frankfurt am Main / Deutschland GMP-Schulung zum Thema risikobasierte Qualifizierung Die GMP-Schulung befasst sich mit der risikobasierten GMP-konformen Qualifizierung von Geräten und Anlagen.
-
08 Feb 202111 Feb 2021Wien / Österreich PBP World Meeting 12. Welttreffen über Pharmazeutik, Biopharmazie und pharmazeutische Technologie
Nachrichten aus aller Welt
Unser internationaler Pressespiegel zeigt eine Auswahl an Nachrichten und neusten Artikel zu den Themen Arzneimittel neuartiger Therapien (ATMP), Chimäre Antigenrezeptor(CAR)-T-Zell-Therapie, Tumor infiltrierende Lymphozyten (TIL) und biotechnologisch bearbeitete Gewebeprodukte (TEP).
Gene therapy making progress in ophthalmology
18.09.2020 | EyeWorld News MagazineIN FOCUS Gene Therapy Gene therapy making progress in ophthalmology by Liz Hillman Editorial Co-Director In some gene ...
Engineered dual-scale poly (ε-caprolactone) scaffolds using 3D printing and rotational electrospinning for bone tissue regeneration
13.09.2020 | Science DirectHighlights • Dual-scale scaffolds fabricated using additive manufacturing and rotational electrospinning. • High rotational velocity ...
Single-Cell Transcriptomic Attributes and Unbiased Computational Modeling for the Prediction of Immunomodulatory Potency of Mesenchymal Stromal Cells
12.09.2020 | bioRxivMesenchymal stromal cells (MSCs) are currently being tested in numerous clinical trials as potential cell therapies for the treatment of ...
Study finds how body cells move within a tissue
11.09.2020 | Phys.orgA new mathematical model may explain how body cells get their shapes and what makes them move within a tissue. The model provides ...
The medicine of the future will include treatments that repair tissues, cells and genes with pathogenic mutations
10.09.2020 | Newsy ListMADRID, 10 Sep. (EUROPA PRESS) – The medicine of the future will include treatments that repair tissues, cells and even genes with ...
Rapid In-Process Monitoring of Lentiviral Vector Particles by High-Performance Liquid Chromatography
10.09.2020 | Science DirectLentiviral vectors (LVs) are a popular gene delivery tool in cell and gene therapy and they are a primary tool for ex vivo transduction of ...
Mitigating Deficiencies in Evidence during Regulatory Assessments of Advanced Therapies: A Comparative Study with Other Biologicals
10.09.2020 | Science DirectAdvanced therapy medicinal products (ATMPs) comprising cell therapy, gene therapy, and tissue-engineered products, offer a multitude of ...
Direct Biologics Initiates Patient Enrollment in the Phase II EXIT COVID-19 Clinical Trial
09.09.2020 | Le Lezard (EN)
Adult Stem Cell Research Shows Promise
09.09.2020 | U S Food and Drug AdministrationHeba Degheidy, M.D., Ph.D., a visiting research associate at FDA, stores stem cell samples for analysis in an FDA laboratory on the ...
Rapid and Durable Remission Observed with Lisocabtagene Maraleucel in R/R Large B-cell Lymphomas
08.09.2020 | Onco'ZineResults of the phase I Transcend study show that lisocabtagene maraleucel (also known as JCAR017), an autologous, CD19-directed, chimeric ...
Mesenchymal Stromal Cells in Viral Infections: Implications for COVID-19
08.09.2020 | DocWire NewsThis article was originally published here Stem Cell Rev Rep. 2020 Sep 7. doi: 10.1007/s12015-020-10032-7. Online ahead of print. ABSTRACT ...
New HIV Gene Therapy, CAR-T Treatments Could be on the Horizon for Patients
08.09.2020 | Gene Therapy NetThe National Institutes of Health (NIH) has backed researchers at the University of Southern California and the Fred Hutchison Cancer ...
Scientists have combined two potent immunotherapies to eliminate big tumors
06.09.2020 | Drew Reports NewsCity of Hope researchers have actually combined two potent immunotherapies– an oncolytic infection and chimeric antigen receptor (CAR) T ...
FDA to Review sBLA for Axi-Cel in R/R Follicular Lymphoma and Marginal Zone Lymphoma
05.09.2020 | Targeted OncologyThe FDA has accepted a supplemental Biologics License Application (sBLA) for axicabtagene ciloleucel (axi-cel; Yescarta) for the treatment ...
Early Study Shows Feasibility of Single Vector Multiplexed shRNA for CAR T Cells
04.09.2020 | Targeted OncologyA first-in-human trial was presented during the 2020 American Society of Clinical Oncology (ASCO) Virtual Scientific Program, which is ...
Valicare – kompetent, zuverlässig & effizient
Sie haben wenig Zeit und möchten trotzdem wissen, welche Dienstleistungen die Valicare GmbH anbietet?